Chemours Company [CC] stock is trading at $14.60, up 1.39%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CC shares have gain 8.55% over the last week, with a monthly amount drifted -17.93%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Chemours Company [NYSE: CC] stock has seen the most recent analyst activity on January 28, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $27. Previously, UBS upgraded its rating to Buy on July 09, 2024, and elevated its price target to $30. On June 07, 2024, Mizuho initiated with a Neutral rating and assigned a price target of $25 on the stock. BMO Capital Markets upgraded its rating to a Outperform and increased its price target to $34 on April 09, 2024. UBS downgraded its rating to a Neutral and reduced its price target to $21 on March 05, 2024. BMO Capital Markets downgraded its rating to Underperform for this stock on February 29, 2024, and downed its price target to $19. In a note dated December 01, 2023, RBC Capital Mkts upgraded an Outperform rating on this stock and boosted its target price from $28 to $40.
Chemours Company [CC] stock has fluctuated between $13.09 and $29.21 over the past year. Currently, Wall Street analysts expect the stock to reach $30 within the next 12 months. Chemours Company [NYSE: CC] shares were valued at $14.60 at the most recent close of the market. An investor can expect a potential return of 105.48% based on the average CC price forecast.
Analyzing the CC fundamentals
Chemours Company [NYSE:CC] reported sales of 5.78B for the trailing twelve months, which represents a growth of 2.42%. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.13 and Total Capital is 0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of7.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.38 points at the first support level, and at 14.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.85, and for the 2nd resistance point, it is at 15.10.
Ratios To Look Out For
For context, Chemours Company’s Current Ratio is 1.68. As well, the Quick Ratio is 0.86, while the Cash Ratio is 0.4. Considering the valuation of this stock, the price to sales ratio is 0.38, the price to book ratio is 3.61 and price to earnings (TTM) ratio is 25.21.
Transactions by insiders
Recent insider trading involved Scarborough Alvenia, SVP Corp Communications & CBO, that happened on Nov 07 ’24 when 7500.0 shares were sold. Officer, Scarborough Alvenia completed a deal on Nov 06 ’24 to buy 7500.0 shares. Meanwhile, Interim Pres. – Titanium Tech Picho Diane I. sold 2684.0 shares on Aug 07 ’24.
